Gujarat Themis Biosyn Limited
BSE: GUJTHEM
Prev Close
358.35
Open Price
363.7
Volume
14,063
Today Low / High
357.55 / 371.15
52 WK Low / High
192.35 / 404.9
Range
347 - 383
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 364.85, reflecting a change of 6.5 (1.81387%). The expected target range on the BSE is 347 - 383. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Gujarat Themis Biosyn Limited Graph
Gujarat Themis Biosyn Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Gujarat Themis Biosyn Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 364.85, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 364.85 | 368.50 | 331.65 - 405.35 |
| 372.15 | 297.72 - 446.58 | ||
| 375.80 | 263.06 - 488.53 | ||
| Bearish Scenario | 364.85 | 361.20 | 325.08 - 397.32 |
| 357.55 | 286.04 - 429.06 | ||
| 353.90 | 247.73 - 460.08 |
Overview of Gujarat Themis Biosyn Limited
ISIN
INE942C01045
Industry
Medical - Pharmaceuticals
Vol.Avg
27,700
Market Cap
39,036,711,250
Last Dividend
0.67
Official Website
IPO Date
2002-01-02
DCF Diff
351.28
DCF
14
Financial Ratios Every Investor Needs
Stock Dividend of GUJTHEM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-04 | September 04, 25 | 0.67 | 0.67 | 2025-09-05 | 2025-10-01 | |
| 2024-07-15 | July 15, 24 | 0.16667 | 0.25 | 2024-07-15 | 2024-08-22 | |
| 2024-02-22 | February 22, 24 | 0.5 | 0.75 | 2024-02-22 | 2024-03-11 | |
| 2023-09-01 | September 01, 23 | 0.13333 | 1 | 2023-09-01 | 2023-10-09 | |
| 2022-12-02 | December 02, 22 | 0.58667 | 4.4 | 2022-12-02 | 2022-12-21 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 150.80 Cr | 57.49 Cr | 95.74 Cr | 0.6349 | 0.00 Cr | 0.00 Cr | 82.08 Cr | 48.77 Cr | 4.48 | 71.55 Cr | 0.3234 |
| 2024-03-31 | 169.82 Cr | 68.74 Cr | 101.08 Cr | 0.5952 | 3.89 Cr | 1.39 Cr | 85.40 Cr | 59.16 Cr | 8.14 | 83.54 Cr | 0.3484 |
| 2023-03-31 | 148.97 Cr | 30.78 Cr | 118.19 Cr | 0.7934 | 2.93 Cr | 1.44 Cr | 80.24 Cr | 57.97 Cr | 7.98 | 80.22 Cr | 0.3891 |
| 2022-03-31 | 114.19 Cr | 20.89 Cr | 93.30 Cr | 0.8170 | 0.45 Cr | 0.83 Cr | 59.82 Cr | 43.62 Cr | 6.01 | 62.10 Cr | 0.3820 |
| 2021-03-31 | 90.43 Cr | 21.11 Cr | 69.32 Cr | 0.7666 | 0.00 Cr | 0.66 Cr | 41.67 Cr | 30.18 Cr | 4.15 | 41.40 Cr | 0.3338 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.55 Cr | 301.31 Cr | 52.93 Cr | 248.3820 Cr | 30.47 Cr | 17.92 Cr | 5.05 Cr | 225.54 Cr | 0.00 Cr | 0.00 Cr | 1.62 Cr | 20.5597 Cr |
| 2024-03-31 | 6.47 Cr | 221.11 Cr | 19.74 Cr | 201.3761 Cr | 2.77 Cr | -3.70 Cr | 3.33 Cr | 129.24 Cr | 0.00 Cr | 0.00 Cr | 31.04 Cr | 16.1592 Cr |
| 2023-03-31 | 6.06 Cr | 166.33 Cr | 17.18 Cr | 149.1459 Cr | 0.42 Cr | -5.64 Cr | 14.62 Cr | 53.26 Cr | 3.79 Cr | 0.00 Cr | 37.36 Cr | 15.2782 Cr |
| 2022-03-31 | 0.46 Cr | 122.50 Cr | 19.18 Cr | 103.3215 Cr | 1.17 Cr | 0.71 Cr | 11.61 Cr | 32.13 Cr | 7.24 Cr | 0.58 Cr | -12.59 Cr | 17.1577 Cr |
| 2021-03-31 | 3.97 Cr | 88.26 Cr | 18.32 Cr | 69.9473 Cr | 4.83 Cr | 0.85 Cr | 6.05 Cr | 21.02 Cr | 7.71 Cr | 0.51 Cr | -34.98 Cr | 15.8231 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 91.0286 Cr | -111.8182 Cr | 26.0143 Cr | -25.1216 Cr | 5.2247 Cr | 11.6939 Cr | -116.1502 Cr | 48.7717 Cr | 28.2588 Cr | -1.8167 Cr | -1.7194 Cr |
| 2024-03-31 | 64.2131 Cr | -55.2119 Cr | -8.5869 Cr | -10.4315 Cr | 0.4142 Cr | 6.4692 Cr | -74.6446 Cr | 59.1632 Cr | 0.0000 Cr | -6.9011 Cr | 11.2921 Cr |
| 2023-03-31 | 0.0004 Cr | -0.0002 Cr | -0.0001 Cr | 0.0002 Cr | 0.0001 Cr | 0.0001 Cr | -0.0002 Cr | 0.0008 Cr | 0.0000 Cr | -12.4354 Cr | 0.0000 Cr |
| 2022-03-31 | 40.3132 Cr | -29.8318 Cr | -13.9951 Cr | 26.4157 Cr | -3.5137 Cr | 0.4608 Cr | -13.8975 Cr | 59.0345 Cr | -3.0727 Cr | -10.0006 Cr | -5.5607 Cr |
| 2021-03-31 | 10.5309 Cr | -2.2515 Cr | -5.1644 Cr | 7.4733 Cr | 3.1150 Cr | 3.9745 Cr | -3.0576 Cr | 40.8819 Cr | -2.0114 Cr | -2.3972 Cr | -0.0195 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 39.08 Cr | 14.70 Cr | 24.39 Cr | 0.6240 | 20.97 Cr | 12.00 Cr | 1.10 | 17.57 Cr | 0.3070 |
| 2024-12-31 | 39.52 Cr | 8.86 Cr | 30.66 Cr | 0.7758 | 17.30 Cr | 12.97 Cr | 1.19 | 19.11 Cr | 0.3282 |
| 2024-09-30 | 34.72 Cr | 18.34 Cr | 16.38 Cr | 0.4718 | 13.96 Cr | 10.57 Cr | 0.97 | 15.71 Cr | 0.3044 |
| 2024-06-30 | 38.83 Cr | 18.48 Cr | 20.35 Cr | 0.5241 | 20.35 Cr | 13.24 Cr | 1.82 | 18.55 Cr | 0.3409 |
| 2024-03-31 | 42.01 Cr | 20.32 Cr | 21.69 Cr | 0.5162 | 20.00 Cr | 15.89 Cr | 2.19 | 21.95 Cr | 0.3781 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.55 Cr | 0.00 Cr | 12.55 Cr | 31.24 Cr | 5.05 Cr | 51.97 Cr | 225.54 Cr | 301.31 Cr | 52.93 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 18.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -223.44 Cr |
| 2024-09-30 | 8.38 Cr | 9.73 Cr | 18.11 Cr | 0.00 Cr | 4.64 Cr | 52.25 Cr | 178.61 Cr | 248.15 Cr | 24.72 Cr |
| 2024-06-30 | -14.58 Cr | 29.17 Cr | 14.58 Cr | 0.00 Cr | 0.00 Cr | 14.58 Cr | 0.00 Cr | 0.00 Cr | -201.38 Cr |
| 2024-03-31 | 8.16 Cr | 9.87 Cr | 8.16 Cr | 27.03 Cr | 3.33 Cr | 47.56 Cr | 129.24 Cr | 221.11 Cr | 19.74 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 12.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 10.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 13.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 15.89 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2024-08-09 | August 09, 24 | 3:2 |
| 2023-10-10 | October 10, 23 | 5:1 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹804.05 | ₹96,279,696,851.00 | ₹756,659.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1954
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
FAQs about Gujarat Themis Biosyn Limited
The CEO is Tapas Bhudebendranath Guhathakurata.
The current price is ₹358.25.
The range is ₹192.35-404.9.
The market capitalization is ₹3,903.67 crores.
The P/E ratio is 80.12.
The company operates in the Healthcare sector.
Overview of Gujarat Themis Biosyn Limited (ISIN: INE942C01045) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹3,903.67 crores and an average daily volume of 27,700 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.67.